These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27690517)

  • 1. The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder.
    Viktorin A; Rydén E; Thase ME; Chang Z; Lundholm C; D'Onofrio BM; Almqvist C; Magnusson PK; Lichtenstein P; Larsson H; Landén M
    Am J Psychiatry; 2017 Apr; 174(4):341-348. PubMed ID: 27690517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Mania After Methylphenidate in Patients With Bipolar Disorder.
    Jefsen OH; Østergaard SD; Rohde C
    J Clin Psychopharmacol; 2023 Jan-Feb 01; 43(1):28-34. PubMed ID: 36584246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer.
    Viktorin A; Lichtenstein P; Thase ME; Larsson H; Lundholm C; Magnusson PK; Landén M
    Am J Psychiatry; 2014 Oct; 171(10):1067-73. PubMed ID: 24935197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin and methylphenidate treatment of a preadolescent with attention deficit hyperactivity disorder and bipolar disorder.
    Hamrin V; Bailey K
    J Child Adolesc Psychopharmacol; 2001; 11(3):301-9. PubMed ID: 11642481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study).
    Hegerl U; Mergl R; Sander C; Dietzel J; Bitter I; Demyttenaere K; Gusmão R; González-Pinto A; Zorrilla I; Alocén AG; Sola VP; Vieta E; Juckel G; Zimmermann US; Bauer M; Sienaert P; Quintão S; Edel MA; Bolyos C; Ayuso-Mateos JL; López-García P; Kluge M
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):185-194. PubMed ID: 29174864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
    Frye MA; Helleman G; McElroy SL; Altshuler LL; Black DO; Keck PE; Nolen WA; Kupka R; Leverich GS; Grunze H; Mintz J; Post RM; Suppes T
    Am J Psychiatry; 2009 Feb; 166(2):164-72. PubMed ID: 19015231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between mood-stabilizing medication and mental health resource use in the management of acute mania.
    Sajatovic M; Gerhart C; Semple W
    Psychiatr Serv; 1997 Aug; 48(8):1037-41. PubMed ID: 9255836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturalistic long-term use of methylphenidate in bipolar disorder.
    Lydon E; El-Mallakh RS
    J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy.
    Ogawa Y; Tajika A; Takeshima N; Hayasaka Y; Furukawa TA
    CNS Drugs; 2014 Nov; 28(11):989-1003. PubMed ID: 25160685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
    Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder.
    Gao K; Kemp DE; Ganocy SJ; Muzina DJ; Xia G; Findling RL; Calabrese JR
    Bipolar Disord; 2008 Dec; 10(8):907-15. PubMed ID: 19594506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study.
    Carlson GA; Loney J; Salisbury H; Kramer JR; Arthur C
    J Child Adolesc Psychopharmacol; 2000; 10(3):175-84. PubMed ID: 11052407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on the Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder.
    Ketter TA; Dell'Osso B
    Am J Psychiatry; 2017 Aug; 174(8):803-804. PubMed ID: 28760025
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequency of stimulant treatment and of stimulant-associated mania/hypomania in bipolar disorder patients.
    Wingo AP; Ghaemi SN
    Psychopharmacol Bull; 2008; 41(4):37-47. PubMed ID: 19015628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
    Moran LV; Ongur D; Hsu J; Castro VM; Perlis RH; Schneeweiss S
    N Engl J Med; 2019 Mar; 380(12):1128-1138. PubMed ID: 30893533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
    Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
    J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention deficit hyperactivity disorder erroneously diagnosed and treated as bipolar disorder.
    Atmaca M; Ozler S; Topuz M; Goldstein S
    J Atten Disord; 2009 Sep; 13(2):197-8. PubMed ID: 19380515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate.
    Kluge M; Hegerl U; Sander C; Dietzel J; Mergl R; Bitter I; Demyttenaere K; Gusmão R; Gonzalez-Pinto A; Perez-Sola V; Vieta E; Juckel G; Zimmermann US; Bauer M; Sienaert P; Quintão S; Edel MA; Bolyos C; Ayuso-Mateos JL; López-García P
    BMC Psychiatry; 2013 Feb; 13():71. PubMed ID: 23446109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders.
    Skoglund C; Brandt L; D'Onofrio B; Larsson H; Franck J
    Eur Neuropsychopharmacol; 2017 Nov; 27(11):1144-1152. PubMed ID: 28935267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.